EGRIFTA WR begins here with a US FDA medicine identity.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
EGRIFTA WR begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Canada. Verify the exact local records below.
Resolve the exact identity of EGRIFTA WR through Current EGRIFTA WR prescribing information from National Library of Medicine, DailyMed. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.
No. A page using the name EGRIFTA WR, local currency, a domestic delivery claim, or a familiar package image is only a lead. EGRIFTA WR is an FDA-approved US tesamorelin prescription product with an exact application, presentation, indication, label, and regulated supply chain. The European Egrifta marketing-authorisation application was withdrawn in 2012. Neither record authenticates research vials, compounded preparations, imported packages, or seller claims, and neither establishes current authorization or supply in another jurisdiction. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
EGRIFTA WR begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Canada. Verify the exact local records below.
Primary identity source: Current EGRIFTA WR prescribing information / National Library of Medicine, DailyMed ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Current EGRIFTA WR prescribing information is maintained by National Library of Medicine, DailyMed. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Current EGRIFTA WR prescribing information ↗Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Drug Product Database ↗Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Choosing a safe online pharmacy ↗Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.
Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.
Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.